(1R,2R)-2-((R)-1-phenylethylamino)cyclohexanol, 98%, 250mg

2-Bromo-4-iodobenzamide, 97.0%, 25g

2,3,4,5-Tetrahydro-benzo[c]azepin-1-one, 97.0%, 1g

2-(4-Methylpyridin-2-yl)acetonitrile, 95+%, 250mg

1-(3-Fluoropyridin-4-yl)ethanone, 95.0%, 10g

7-Chloroquinazoline, 97%, 250mg

5-Benzyl L-Glutamate N-Carboxyanhydride>98.0%(HPLC)(T)5g

7-Nitro-3,4-dihydro-2H-benzo[b][1,4]dioxepine, 95.0%, 250mg

(R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

1,2,3-Trichloro-4-nitrobenzene, 95.0%, 25g

4-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde, 97.0%, 1g

Sodium 3-[[(dimethylamino)thioxomethyl]thio]propanesulphonate, 99.0%, 500g

2-Amino-4-(3-pyridyl)thiazole, 97.0%, 250mg